Carisma Therapeutics (CARM) Institutional Ownership $0.04 +0.00 (+3.99%) As of 03:58 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Carisma Therapeutics (NASDAQ:CARM)CurrentInstitutional OwnershipPercentage44.27%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$1.22MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$33.14K Get CARM Insider Trade Alerts Want to know when executives and insiders are buying or selling Carisma Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CARM Institutional Buying and Selling by Quarter Carisma Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2025Jane Street Group LLC150,810$59K0.0%N/A0.361% 5/6/2025Universal Beteiligungs und Servicegesellschaft mbH200,000$62K0.0%N/A0.479% 2/17/2025Millennium Management LLC120,157$50K0.0%-15.7%0.288% 2/13/2025Renaissance Technologies LLC231,357$97K0.0%+11.9%0.554% 11/19/2024Barclays PLC549,305$539K0.0%+3,661,933.3%1.316% 11/16/2024Geode Capital Management LLC259,184$254K0.0%-8.5%0.621% 11/15/2024Barclays PLC549,305$539K0.0%+3,661,933.3%1.316% 11/15/2024Wexford Capital LP34,861$34K0.0%+75.5%0.083% 9/16/2024Point72 Asia Singapore Pte. Ltd.26,006$40K0.0%N/A0.063% 8/15/2024Point72 Asia Singapore Pte. Ltd.26,006$40K0.0%N/A0.063% Get the Latest News and Ratings for CARM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Carisma Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/15/2024TPG GP A LLC842,031$1.28M0.0%-42.0%2.027% 8/9/2024Renaissance Technologies LLC139,360$212K0.0%-38.3%0.335% 5/10/2024Vanguard Group Inc.1,579,961$3.59M0.0%+0.7%3.803% 5/7/2024Empowered Funds LLC26,984$61K0.0%-43.9%0.065% 2/14/2024Trustees of The University of Pennsylvania1,252,107$3.67M10.3%-28.9%3.102% 10/13/2023SG Americas Securities LLC13,653$58K0.0%N/A0.034% 9/21/2023Barclays PLC5,312$47K0.0%N/A0.013% 8/4/2023American International Group Inc.12,834$113K0.0%N/A0.032% 7/27/2023EA Series Trust40,434$355K0.0%N/A0.100% 6/15/2023Trustees of The University of Pennsylvania2,182,812$6.77M6.6%N/A5.422% 5/15/2023Wittenberg Investment Management Inc.46,703$145K0.1%N/A0.459% 5/12/2023Deuterium Capital Management LLC51,256$159K0.2%N/A0.504% 5/10/2023Connor Clark & Lunn Investment Management Ltd.14,796$46K0.0%N/A0.145% 5/3/2023Jump Financial LLC17,542$54K0.0%N/A0.172% 5/1/2023Virtu Financial LLC15,335$48K0.0%N/A0.151% 4/27/2023Stratos Wealth Partners LTD.19,899$62K0.0%N/A0.195% 4/24/2023Blodgett Wealth Advisors LLC29,660$92K0.1%N/A0.291% 4/14/2023BML Capital Management LLC411,398$1.28M1.1%N/A4.041% (Data available from 1/1/2016 forward) CARM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CARM shares? During the previous two years, 12 institutional investors and hedge funds held shares of Carisma Therapeutics. The most heavily invested institutionals were Trustees of The University of Pennsylvania ($3.67M), Vanguard Group Inc. ($3.59M), TPG GP A LLC ($1.28M), Barclays PLC ($539K), Geode Capital Management LLC ($254K), Renaissance Technologies LLC ($97K), and Universal Beteiligungs und Servicegesellschaft mbH ($62K).Learn more on Carisma Therapeutics' institutional investors. What percentage of Carisma Therapeutics' stock is owned by institutional investors? 44.27% of Carisma Therapeutics' stock is owned by institutional investors. Learn more on CARM's institutional investor holdings. Which institutional investors have been buying Carisma Therapeutics' stock? The following institutional investors have purchased Carisma Therapeutics' stock in the last 24 months: Barclays PLC ($1.10M), Universal Beteiligungs und Servicegesellschaft mbH ($200K), Jane Street Group LLC ($150.81K), Point72 Asia Singapore Pte. Ltd. ($52.01K), Renaissance Technologies LLC ($24.60K), Wexford Capital LP ($15K), and Vanguard Group Inc. ($11.20K). How much institutional buying is happening at Carisma Therapeutics? Institutional investors have bought a total of 1,488,990 shares in the last 24 months. This purchase volume represents approximately $1.22M in transactions. Which of Carisma Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Carisma Therapeutics stock in the last 24 months: Geode Capital Management LLC ($24.22K), and Millennium Management LLC ($22.37K). How much institutional selling is happening at Carisma Therapeutics? Institutional investors have sold a total of 46,589 shares in the last 24 months. This volume of shares sold represents approximately $33.14K in transactions. Related Companies Evogene Major Shareholders Polyrizon Major Shareholders Sonoma Pharmaceuticals Major Shareholders Qualigen Therapeutics Major Shareholders Pasithea Therapeutics Major Shareholders CNS Pharmaceuticals Major Shareholders Onconetix Major Shareholders Clearmind Medicine Major Shareholders Aptevo Therapeutics Major Shareholders InMed Pharmaceuticals Major Shareholders This page (NASDAQ:CARM) was last updated on 10/23/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carisma Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carisma Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
